Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2011

Jun 23, 2011

30583_dirs_2011-06-23_50453a17-0642-4468-bed6-e5dd7fcb8d1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-06-22

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-22 Common Stock M 1000 Acquired 21005 Direct
2011-06-22 Common Stock M 937 $14.39 Acquired 21942 Direct
2011-06-22 Common Stock M 625 $17.33 Acquired 22567 Direct
2011-06-22 Common Stock M 83 $17.86 Acquired 22650 Direct
2011-06-22 Common Stock S 1645 $25.9252 Disposed 21005 Direct
2011-06-23 Common Stock S 371 $25.555 Disposed 20634 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-06-22 Stock Option (right to buy) $14.39 M 937 Disposed 2019-05-11 Common Stock (937) Direct
2011-06-22 Stock Option (right to buy) $17.33 M 625 Disposed 2017-06-06 Common Stock (625) Direct
2011-06-22 Stock Option (right to buy) $17.86 M 83 Disposed 2028-12-16 Common Stock (83) Direct
2011-06-22 Restricted Stock Units $0 M 1000 Disposed Common Stock (1000) Direct

Footnotes

F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.

F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 20, 2010.

F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $25.58 to $26.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The price in Column 4 is a weighted average price. The prices actually received ranged from $25.33 to $25.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.

F6: Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.

F7: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.

F8: Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 22, 2010 and June 22, 2011.